RecruitingNCT01102569
Pancreatic Cancer Genetics
Molecular Genetics and Epidemiology of Pancreatic Cancer in Ashkenazi Jewish Patients
Sponsor
Columbia University
Enrollment
100 participants
Start Date
Jan 1, 2008
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to determine the frequency of the three most common BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) genetic mutations that are commonly found in Ashkenazi Jewish patients with pancreatic cancer. Testing for BRCA1 and BRCA2 mutations in relatives of hereditary pancreatic cancer patients may have a significant impact; allowing for early screening, treatment, and resection of pre-malignant tissue or malignant lesions.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria3
- Patients diagnosed with pancreatic cancer.
- Patients are of Ashkenazi Jewish descent.
- Patients have been Columbia Pancreatic Cancer Prevention Program Registry and Tissue Bank for High-Risk Individuals (IRB-AAAA6154).
Exclusion Criteria2
- Inability to provide informed consent.
- Under the age of 18 years old.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01102569
Related Trials
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT0407530518 locations
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
NCT060919307 locations
DESTINY-PANTUMOUR04
NCT0712400015 locations